Letter in response to Othman & Favaloro "Comparison of two ways of performing ristocetin-induced platelet agglutination (RIPA) mixing study for diagnosis of type 2B VWD".

Soleimani, Reza;Khourssaji, Mehdi;Cabo, Julien;Guldenpfennig, Maite;Mullier, François;et.al.
(2023) Research and Practice in Thrombosis and Haemostasis — Vol. 7, n° 6, p. 102165 [1-3] (2023)

Files

SoleimaniRResPractThrombHaemost2023.pdf
  • Open Access
  • Adobe PDF
  • 775.3 KB
Download

Details

Authors
  • Soleimani, RezaUCLouvain
    Author
  • Khourssaji, MehdiUCLouvain
    Author
  • Cabo, JulienUCLouvain
    Author
  • Guldenpfennig, MaiteUCLouvain
    Author
  • Baudar, JustineUCLouvain
    Author
  • Chatelain, BernardUCLouvain
    Author
  • Devalet, BérangèreUCLouvain
    Author
  • Bareille, MarionUCLouvain
    Author
  • Mullier, FrançoisUCLouvain
    Author
Show more
Abstract
(en) TO THE EDITOR, Platelet type-von Willebrand disease (PT-VWD) is one of the rarest inherited bleeding disorders and can be misdiagnosed as subtype 2B VWD (2B-VWD) because they both share similar laboratory profile and clinical manifestations [1]. The differential diagnosis between 2B-VWD and PT-VWD is of utmost importance to avoid misdiagnosis and ultimately mistreatment. Typically, when there is excessive agglutination with low-concentration ristocetin (<0.5-0.7 mg/mL), a 2B-VWD or PT-VWD should be suspected. [...]
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Soleimani, R., Khourssaji, M., Cabo, J., Guldenpfennig, M., Baudar, J., Chatelain, B., Devalet, B., Bareille, M., & Mullier, F. (2023). Letter in response to Othman & Favaloro “Comparison of two ways of performing ristocetin-induced platelet agglutination (RIPA) mixing study for diagnosis of type 2B VWD”. Research and Practice in Thrombosis and Haemostasis, 7(6), 102165 [1-3]. https://doi.org/10.1016/j.rpth.2023.102165 (Original work published 2023)